INVICTUS EXECUTIVES TO REPRESENT CANNABIS AT WORLD ECONOMIC FORUM IN DAVOS, SWITZERLAND JANUARY 23 at 4pm GMT
January 18 2019 - 10:26AM
InvestorsHub Cannabis NewsWire
Vancouver, BC -- January 18, 2019 --
InvestorsHub NewsWire -- INVICTUS MD STRATEGIES CORP. ("Invictus"
or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS1) is pleased to announce that George E. Kveton,
President and CEO of Invictus, and Paul Sparkes, Chairman of
Invictus, will attend CannaTech at the World Economic Forum in
Davos, Switzerland for a panel discussion entitled How to Build
International Brands in the Cannabis Industry on Wednesday,
January 23, 2019 at 4:00 p.m. GMT. Invictus will present alongside
top international cannabis industry leaders including Bruce Linton,
CEO of Canopy Growth Corporation.
CannaTech, to be held January 22-25, 2019, is
widely recognized as the premier cannabis event. It is the only
event of its kind with a truly global focus that offers senior
industry leaders, medical and scientific experts, and new ventures
the platform to come together, drive innovation, form partnerships
and promote knowledge exchange. CannaTech will feature dynamic
presentations that focus on science, research, finance, medicine,
tech, agriculture, innovation and government
policy.
“Right now, we are witnessing a global shift
in the discussion around cannabis and its impact on the future of
medicine and adult recreational enjoyment,” said George E. Kveton,
President and CEO of Invictus. “By hosting a cannabis summit in
concert with World Economic Forum, CannTech provides an incredible
opportunity to share the Invictus story with the world’s top
economic and political leaders.”
Paul Sparkes, Chairman of Invictus added. “It
is an honour to represent Invictus on the international stage at
this critical time of growth in our industry,” said Paul Sparkes,
Chairman of Invictus. “As we look to new markets to build
partnerships in business, we also find value in sharing experiences
from legalization of recreational cannabis in Canada so that we may
work together to build a strong, successful global industry that
benefits patients and consumers
alike.”
For more information, please visit
www.invictus-md.com.
On Behalf of the
Board,
George E.
Kveton
Chief Executive Officer and
Director
Jessica Martin
Vice President, Public Relations and
Regulatory Affairs
(833) 879-4363
About
Invictus
Invictus is a global cannabis company offering
a selection of products under a wide range of brands. Our
integrated sales approach is defined by five pillars of
distribution including medical, adult-use, international, Licensed
Producer to Licensed Producer and retail
stores.
Invictus has partnered with business leaders
to convey our corporate vision, including KISS music legend and
business mogul Gene Simmons as our Chief Evangelist Officer. To
meet growing demand, Invictus is expanding its cultivation
footprint, with three cannabis production facilities licensed under
the Cannabis Act and Cannabis Regulations in Canada. To accommodate
international sales, Invictus’ wholly-owned subsidiary, Acreage
Pharms Ltd. (“Acreage Pharms”), has designed and is currently
building its Phase 3 purpose-built cultivation facility to be
European Union Good Manufacturing Practices (“EU-GMP”) compliant.
The Company is targeting up to 50 percent of production to medical
cannabis. To ensure consistency in quality and supply, Invictus
maintains all aspects of the growing process through its
subsidiary, Future Harvest Development Ltd. (“Future Harvest”), a
high-quality fertilizer and nutrients manufacturer. Invictus drives
sustainable long-term shareholder value through a diversified
product portfolio with over 70 Health Canada approved strains and a
multifaceted distribution strategy including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores. For more information visit www.invictus-md.com.
Neither the Canadian Securities Exchange nor
its Regulation Services Provider accepts responsibility for the
adequacy or accuracy of this release.
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Oct 2023 to Oct 2024